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Conamitsnt use of a pacemaker and an automatic inrplant- 
rter=defibrillator (AIICD) is 
hteractioms were 
The automatic implantable cardioverter-defibrillator (AICD) 
has been demonstrated to successfully convert malignant 
ventricular arrhythmias to sinus rhythm (l-3). Although the 
device was initially used only in patients with recurrent 
cardiac arrest, the indications for its placement have ex- 
panded and its use has increased markedly. Some (15% to 
20%) of these patients with an implantable defibrillator also 
require concomitant pacemaker therapy for management of 
associated bradyarrhythmias (3-5). Conversely, patients 
treated with an antitachycardia pacemaker for ventricular 
tachycardia require a backup implantable defibrillator be- 
cause of the risk of acceleration of ventricular tachycardia or 
the induction of ventricular fibrillation (6-S). As the number 
of patients with both devices grows, so does the importance 
of understanding the interactions between them. 
Isolated case reports and small series (9-l I) have de- 
scribed potentially harmful interactions. For the most part, 
these reports have drawn attention to the potentially adverse 
effects of a pacemaker on the function of the implantable 
defibrillator. Less attention has eels focused on the 
of the defibrillator on pacemaker sys 
tion, some investigators (10.11) have 
otentially adverse inte 
clinical importance 0 
use the number of patients reported in 
these studies was small and the lengt of follow-up was 
limited as a result of the investigational nature of the AICD 
before 1985. In addition, many patients undergoing pace- 
maker implantation have a preexisting implanted AICD and, 
therefore. decisions regarding the possible need for reoper- 
ating on the AICD pocket to directly record from the AICD 
sensing leads are also important. 
The objective of our study was to review the 8 year Johns 
Hopkins Hospital experience in 30 patients with both an 
implanted pacemaker and an implantable defibrillator to 
evaluate the incidence and clinical significance of interac- 
tions between these devices. We report not only on the effect 
of pacemaker function on implantable defibrillator function, 
but also the converse. 
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lysis of records. Between January 1980 
and June 9988, 976 patients underwent placement of an 
AICD at The Johns Hopkins Hospital. Thirty (17%) of these 
@lm by the American College of Cardiology 07351097/90/%3.50 
screem b adverse betwee 
aracter~st~cs of t&e 
eir mean age was 
Twenty-two patients had coronary artery disease, five had 
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Table 1. AICD and Pacemaker Models in 30 Patients 
AlCD Model AICD* AICD Pacemaker I 
Sensing Lead Shocking Lead Pacemakert 
I 2 3 Posilion Configuration Lead Position Model idumber Mode UnilBi 
AIDB 1510 
AIDB AIDB 
AlDB 1520 
AIDB 
AIDB AIDB I520 
AID 
AIDB 1520 
AIDB 1520 
1520 
AIDB 
AIDB 1510 
AIDB AIDB 
AIDB AIDB 152Q 
AIDB 
1520 
AIDB 
1520 
AIDB AIDB 
AIDB AIDB 1510 
AIDB 1520 
AIDB 
l5to 
AIDB 1520 
AID 
AID AIDB AIDB 
AIDB 1520 
AID AlDB 
AIDB AIDB I510 
AIDB AIDB 
Endocardial 
Epicardial 
Epicardial 
Epicardial 
Epicardial 
SW/patch 
Epicardial 
Epicardial 
Epicardial 
Epicardial 
Epicardial 
Epicardial 
Epicardial 
Epicardial 
Epicardial 
Epicardial 
Epicardial 
Epicardial 
Epicardial 
Epicardial 
Epicardial 
Endocardial 
Epicardial 
WC/patch 
Epicardial 
Endocardial 
Epicardial 
Epicardial 
Endocardial 
Epicardial AIDB AlDB 1520 
Pal&/patch 
SVC/patch 
Pal&/patch 
SVClpatch 
Patch/patch 
SW/patch 
WC/patch 
SVClpatch 
SVClpatch 
SVClpatch 
SVClpatch 
SVCipatch 
SVClpatch 
Pat&patch 
Patch/patch 
Patch/patch 
Patch/patch 
SVClpatch 
SVClpatch 
Patch/patch 
SVClpatch 
Pat&patch 
SVClpatch 
SVClpckn 
SVClpatch 
SVClpatch 
SVClpatch 
SVClpatch 
svclpatch 
SVClpatch 
Endocardial 
Endocardial 
Endocardial 
Endocardial 
Endocardial 
Endocardial 
Epicardial 
Endocardial 
Endocardial 
Endocardial 
Endocardial 
Endocardial 
Endocardial 
Epicardial 
Endocardial 
Endocardial 
Endocardial 
Endocardial 
Endocardial 
Endocardial 
Endocardial 
Endocardial 
Endocardial 
Endocardial 
Epicardial 
Endocardial 
Endocardial 
Endocardial 
Endocardial 
Endocardial 
Pacesetter 262 
CPI 630 
Pacesetter 2010 
Pacesetter 286 
CPI 630 
Cordis 415A 
Pacesetter 262 
Medtronic 7086 
Pacese:ter 262 
Pacesetter 262 
Pacesetter 850 
Medtronic 5984 
Pacesetter 262 
Medtronic 8040 
CPl630 
intermedics 262-14 
Medtronic 5984 
Telectronics 4171 
Pacesetter 262 
Intermedic 259.01 
Pacesetter 202 
Pacesetter 262 
CPI 630 
Medtronic 5985 
Cordis 284A 
Medtronic 5985 
VVVFli 
VWBi 
DDDlBi 
VVliBi 
DDDlBi 
VW&i 
VVllUni Cordis 415A 
VVllBi 
vvm 
VV~iB~ 
VVllBi 
VV~,~~/~i 
VW& 
DVUBi 
DDWBi 
VVVBi 
VVVBi 
Medlronic 7006 VVllBi 
Pacesetter 2010 
fvledtronic 5984 
edtronic 5984 
VVllBi 
VVllBi 
VVVBi 
*All endocardial AlCD sensing leads were in the right ventricle: fall epicardial pacemaker leads were on the left ventricle. AI(C) = automatic implantahle 
(cardioverterl-defibrillator; Bi = bipolar: DDD = dual chamber. demand; DDDR = dual chamber, demand, rate responsive; DVl = dual chamber pacing. 
ventricular sensing. inhibited; SVC = superior vena cava; Uni = unipolar; VVI = ventricular demand; VVlR = ventricular demand, rate responsive; VW, 
MB = ventricular demand, antitachycardia. 
fibrillation resulting from pacemaker stimulus oversensing, 
and 4) pacemaker reprogramming after AICD discharge. 
Transient 
(Fig. 1). Figure 1 shows a recording of a surface lectrocar- 
diogram and an intracardiac electrogram after AICD dis- 
charge in a patient with a bipolar dual chamber pacemaker 
programmed to the ventricular demand mode at a rate of 50 
beatslmin (Patient 17). After AICD discharge, both failure to 
capture and sense were observed. These pacing abnormali- 
ties persisted >56 s before normal pacemaker function 
resumed. Similar pacemaker dysfunction with failure to 
sense or capture, or both, was observed in a total of seven 
patients. This was a transient phenomenon a d lasted c IO s 
in four patients, 10 to 35 s in two patients and X6 s in one 
patient (Fig. I). One additional patient with a unipolar 
pacemaker demonstrated persistent failure to sense lasting 
>lO min; his pacemaker was subsequently changed to a 
bipolar configuration because of potential inhibition of the 
AKD. In no patient did this interaction become clinically 
r at the time of defib~~l~t~Q~ kres 
this interaction. 
pacemaker stimulus and the ev 
tion during asynchronous pacing. 
recording was made by placi 
AICD unit that beeps ynchronously with sensed intracar- 
diac events (R wave or 
programmed to the async 
double counting due to the pacemaker spike. This patient 
had a single chamber demand ventricular pacemaker with 
bipolar endocardial pacemaker leads, bipolar epicardial 
N? 
Ye5 
Yes 
Yes 
Yes 
NQ 
No 
KC5 
NO 
Yes 
Yes 
Yes 
NO 
No 
No 
No 
NO 
0 
No 
No 
N0 
No 
No 
MO 
NO 
No 
CapbIn 
Sense 
Sense 
Sense (unipolar only) 
as in Table 1. 
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sensing lead placed on the high lateral wall of the left 
ventricle. In the top panel the pacemaker is programmed to 
standard outputs in the dual chamber demand mode. Despite 
intermittent pacing, appropriate AICD sensing with termina- 
tion of the ventricular fibrillation occurred. The middle panel 
shows the pacemakc : reprogrammed to ual chamber asyn- 
chronous mode. Appropriate s nsing and termination f the 
ventricular fibrillation again occurred. In the lower panel the 
pacemaker was programmed to the dual chamber asynchro- 
nous mode but at maximal output (IO V at 1.6 ms); the AICD 
did not recognize the induced ventricular fibrillation and the 
patient was rescued with external cardioversion. Two other 
patients who had a unipolar pacemaker demonstrated inbi- 
bition of the AICD at standard pacemaker outputs. The 
latter problem was corrected by revising the pacemakers to 
the bipolar configuration. Thus, both unipolar and bipolar 
pacemakers have the potential for this interaction even 
atient in Figure 4 had a 
in place programmed to the ven 
mode at a rate of 85 beatslmin. The patient had endocardial 
pacemaker leads and two patches for defibrillation. After 
each separate days, the 
ace er was noted to nd on j~te~ogat~o 
in the veentriculat-, 
t 
diographic signals ( 
with both. 
was found to be in the backu 
415 ventricular de 
tion system. After one but not every 
pacemaker p ogrammed to the ventricul 
the time of his first AICD discharge. 
endocardial pacemaker lead positioned at the right ventric- 
ular apex and a left v 
de~b~lIat~on syste 
pacemaker p ogram tu 
Figure 3. Patient 5.Lead V, electrocardiogram and femoral blood 
pressure (BP) during automatic implantable cardioverter- 
defibrillator (AICD) testing. During the three tests shown the 
patient’s bipolar dual chamber pacemaker was programmed in the 
dual chamber demand (DDD) mode (5 V at 0.6 ms), dual chamber 
asynchronous (DOO) (5 V at 0.6 ms) and DO0 (10 V at I.6 ms), 
respectively. Incomplete suppression of pacemaker outputs is seen 
while in the DDD mode. Failure of AICD detection of ventricular 
fibrillation (VF) is seen only with the pacemaker programmed at 
DO0 (IO V at 1.6 ms). AC = ahe 
sinus rhythm. 
BP 
JACC VQI. 16. No. 3 
-73 
demonstrated a potential 
In this series 17% of p 
ce. In contrast, AIC 
~~tat~o~ attest to 
common indication for pacemaker placement was heart 
block. An antitachycardia p cemaker was placed for man- 
terval ~etweem s 
series of 30 patients, 
672 CALKINS ET AL. 
AICDPACEMAKER INTERACTlONS 
at 10 V with the AICD in the telemetry mode. Thus, 
oversensing of pacemaker stimuli occurs extremely infre- 
quently with bipolar pacemakers but may be intermittent and 
the potential exists for false firing of an implantable d&b& 
tator. Our data, as well as those of others, therefore suggest 
tha:. this type of clinical interaction, common with unipolar 
pacemakers, i  distinctly uncommon when using bipolar 
pacemakers. No clinical interactions of this type were noted 
in our patient group despite not performing specialized 
mapping studies intraoperatively. Thus, tbe recommenda- 
tions of others (10,ll) to perform these studies in every 
patient may be overstated. 
Pathue to detect ventricutar fibr atise. This may occur 
in patients with a unipolar pacemaker in piace. This well 
documented interaction occurred in one patient with a 
unipolar ventricular demand pacemaker atthe time of AICD 
implantation a d in a second patient only when his dual 
chamber bipolar pacemaker was programmed to dual cham- 
ber asynchronous mode at maximal output (10 V at 1.6 ms). 
In no patient with a bipolar pacemaker at standard output did 
inhibition of AICD firing occur. Pacemaker-induced failure 
to sense ventricular tachyarrhythmias h s been reported 
clinically only with unipolar pacemakers (9,13,22). In our 
cases this was noted at the time of standard initial testing. 
Although failure of ventricular fibrillation detection was not 
a clinically important factor with bipolar pacemakers at
standard output and was most often detected at the time of 
initial testing in our series, it may occur with concomitant 
use of antiarrhythmic drugs that may increase pacing thresh- 
old and therefore be associated with higher programmed 
pacing outputs. Thus, this potentially lethal interaction 
should be screened for at the time of placement second 
device and at the time a higher pacing output is mmed, 
even though it is uncommon. 
. 
3 
&%I of the 30 patients inour series. In two pattents 
discharge r programmed the
of ventricular syachro~o~s 
model 415A) and ventricul 
(Medtronic model 7006). In the third patient with an Inter- 
medics Intertach pacemaker initially programmed to the 
ventricular demand mode at 65 beatslmin, an AICD dis- 
charge resulted in the pacemaker program turning the device 
off. In one of these patients reprogramming was not seen at 
the time of predischarge t sting and ap 
intermittent phenomenon. The potential for electromagnetic 
interference to reprogram a single or dual chamber to the 
baCkUP mode is well established (23). Most pacemakers 
respond to electromagnetic interference by reverting to a 
backup or interference mode (ventricular demand or asyn- 
chronous Pa&O in a highly predictable and reproducible 
fashion. Although optimal dual chamber pacemaker function 
wgl be temporarily ost, marked bradycardia is prevented. 
has been reported exclusively in p 
pacemaker ( li 5,23-X). To our know1 
a pacemaker after discharge of an 
10n so as to posttton t 
at the site of the smallest stimu 
sensing leads to assure that the 
cantly larger than the pacem 
screening tests include 1) p~onoc~r 
is in the e~ectrop~ysio~ogy 
asynchronous mode with 
double counting, 2) testing 
quences of implantation f the two devices and necessary 
of our patients had their 
clinically irnpo~a~~ and heretofore unreported complication 
of AICD discharge, was relatively common (10%). Finally, 
AICD-induced pacemaker malfunction was common but in 
our series and others it was clinically unimportant. 
~~~e~dat~o~s. On the basis of our experience, as 
as other published ata, several recommendations can
be made to minimize interactions between pacing systems 
and implantable d tibrillators. First and foremost, unipolar 
pacemakers are clearly incompatible with the implantable 
defibrillator. Second, where possible, the pacemaker leads 
and the AED sensing lead should be placed in separate 
cardiac hambers as far apart as possible. If the AICD is 
placed as the second procedure, it is visabie to minimize 
the pacemaker spike amplitude on the AICD sensing lead 
recording. We routinely place the epicardial AICD sensing 
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